Highlights

  • Apple contests ban on Apple Watch imports amid patent dispute.
  • Legal battle intensifies between Apple and medical tech company Masimo.

Latest news

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

India-UK trade deal likely by May 1; Europe deal expected by year-end

India-UK trade deal likely by May 1; Europe deal expected by year-end

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

Changing Aspirations of Premium Homebuyers in NCR

Changing Aspirations of Premium Homebuyers in NCR

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

Apple puts emergency request to stop US watch import ban

The prohibition, sparked by Masimo's allegations of Apple integrating its pulse oximetry tech into the Apple Watch and violating patents, impacts Apple's Series 9 and Ultra 2 smartwatches featuring blood-oxygen monitoring features.

Apple puts emergency request to stop US watch import ban

As per a Reuters report, Apple has taken action in response to a recent decision by the U.S. International Trade Commission (ITC) to impose a ban on the import and sales of certain Apple Watches in the United States. This move follows a complaint filed by medical monitoring technology company Masimo, alleging patent infringement by Apple.

The ban, initiated after Masimo accused Apple of incorporating its pulse oximetry technology into the Apple Watch and infringing on its patents, affects Apple's Series 9 and Ultra 2 smartwatch models, which include blood-oxygen level monitoring capabilities.

Despite efforts by Apple to appeal the decision, including an emergency request filed with the U.S. Court of Appeals for the Federal Circuit, the company faced setbacks as the ITC's ruling remained in place. Apple’s plea for a halt in the ban until a decision on redesigned watch versions' patent infringement was rejected.

In response to the ban, Apple temporarily ceased the sale of the affected smartwatch models in the U.S. market but clarified that its Apple Watch SE and previously sold watches remain unaffected. The company has also continued to sell the banned models through various retailers like Amazon, Best Buy, and Walmart.

This legal battle highlights the intensity of intellectual property disputes within the tech industry, with Masimo asserting that Apple recruited its employees and unlawfully integrated its technology into the Apple Watch. However, Apple has contested these claims, emphasizing its disagreement with the ITC's decision and expressing its commitment to resolving the issue to ensure the return of the affected products to customers as soon as possible, reported Reuters.

The situation underscores the complexities of patent disputes between tech giants and smaller companies, indicating a potentially protracted legal process ahead. Analysts predict that an Apple appeal could prolong the final resolution by approximately another year, impacting the availability of the banned Apple Watch models in the U.S. market.

Apple's wearable technology business, which encompasses products like the Apple Watch and AirPods, has been a significant revenue driver for the company, generating billions in revenue during the third quarter of 2023, reported Reuters.


Also Watch: Apple's iPhone 17 may be developed in India: Report

ADVERTISEMENT

Up Next

Apple puts emergency request to stop US watch import ban

Apple puts emergency request to stop US watch import ban

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

ADVERTISEMENT

editorji-whatsApp

More videos

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.